Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
- PMID: 36791549
- DOI: 10.1016/j.compbiomed.2023.106637
Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
Abstract
Background: Hyperuricemia is a more popular metabolic disease caused by a disorder of purine metabolism. Our previous study firstly screened out a natural product Isobavachin as anti-hyperuricemia targeted hURAT1 from a Chinese medicine Haitongpi (Cortex Erythrinae). In view of Isobavachin's diverse pharmacological activities, similar to the Tranilast (as another hURAT1 inhibitor), our study focused on its potential targets and molecular mechanisms of Isobavachin anti-hyperuricemia based on network pharmacology and molecular docking.
Methods: First of all, the putative target genes of compounds were screen out based on the public databases with different methods, such as SwissTargetPerdiction, PharmMapper and TargetNet,etc. Then the compound-pathways were obtained by the compounds' targets gene from David database for Gene Ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analysis. The cross pathways of compound-pathways and the diseases pathways of hyperuricemia from Comparative Toxicogenomics Database were be considered as the compound-disease pathways. Next, based on the compound-disease pathways and the PPI network, the core targets were identified based on the retrieved disease-genes. Finally, the compound-target-pathway-disease network was constructed by Cytoscape and the mechanism of isobavachin anti-hyperuricemia was discussed based on the network analysis.
Results: Our study demonstrated that there were five pathways involved in Isobavachin against hyperuricemia, including Drug metabolism-other enzymes, Metabolic pathways, Bile secretion, Renin-angiotensin system and Renin secretion. Among the proteins involved in these pathways, HPRT1, REN and ABCG2 were identified as the core targets associated with hyperuricemia, which regulated the five pathways mentioned above. It is quite different from that of Tranilast, which involved in the same pathways except Bile secretion instead of purine metabolism.
Conclusion: This study revealed Isobavachin could regulate the pathways including Drug metabolism-other enzymes, Metabolic pathways, Bile secretion, Renin-angiotensin system, Renin secretion by core targets HPRT1, REN and ABCG2, in the treatment of hyperuricemia effect. Among them, the Bile secretion regulated by ABCG2 probably would be a novel pathway. Our work provided a theoretical basis for the pharmacological study of Isobavachin in lowering uric acid and further basic research.
Keywords: Hyperuricemia; Isobavachin; Molecular mechanism; Network pharmacology; Tranilast.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia.Biomed Res Int. 2023 Feb 9;2023:2507683. doi: 10.1155/2023/2507683. eCollection 2023. Biomed Res Int. 2023. Retraction in: Biomed Res Int. 2024 Jan 9;2024:9754274. doi: 10.1155/2024/9754274. PMID: 36817858 Free PMC article. Retracted.
-
Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.Comb Chem High Throughput Screen. 2022;25(10):1785-1804. doi: 10.2174/1386207325666220523151119. Comb Chem High Throughput Screen. 2022. PMID: 35616676
-
[Mechanism of Zixin Biqiu Granules in treatment of allergic rhinitis based on network pharmacology and molecular docking technology].Zhongguo Zhong Yao Za Zhi. 2022 Oct;47(19):5344-5352. doi: 10.19540/j.cnki.cjcmm.20220524.401. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36472042 Chinese.
-
Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology.Evid Based Complement Alternat Med. 2020 Oct 22;2020:3023127. doi: 10.1155/2020/3023127. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33149752 Free PMC article. Review.
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous